Dehydroepiandrosterone: all 92 studies that test it
Page 1 of 1. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.RecruitingNCT07843927Phase 3
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerRecruitingNCT07407647Phase 2
- Growth Hormone and Dehydroepiandrosterone Role in Vitro FertilizationRecruitingNCT07323329Phase 2/3
- Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )Not yet recruitingNCT07179952Phase 2
- Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast CancerNot yet recruitingNCT06611514Phase 3
- Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II TrialNot yet recruitingNCT05935761Phase 2
- The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian RespondersNot yet recruitingNCT05900661Phase 2/3
- Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)RecruitingNCT05263557Not applicable
- Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary SyndromeRecruitingNCT05246865Not applicable
- The Effects of Fluoxetine and/or DHEARecruitingNCT03228732Early Phase 1
- Effect of DHEA on Patients With Poor Ovarian RespondsRecruitingNCT02432248Not applicable
- Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase InhibitorsTerminatedNCT04493333Phase 2Results posted
- Effects of DHEA in Pulmonary HypertensionCompletedNCT03648385Phase 2Results posted
- The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor RespondersTerminatedNCT02357472Not applicableResults posted
- Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With MenopauseCompletedNCT02013544Phase 3Results posted
- Topical DHEA Against Vaginal AtrophyCompletedNCT01846442Phase 3Results posted
- Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal SymptomsCompletedNCT01376349Phase 3Results posted
- Dehydroepiandrosterone (DHEA) Against Vaginal AtrophyCompletedNCT01358760Phase 3Results posted
- DHEA Against Vaginal Atrophy - 3-Month Efficacy StudyCompletedNCT01256684Phase 3Results posted
- DHEA Against Vaginal Atrophy - Safety Study of 12 MonthsCompletedNCT01256671Phase 3Results posted
- DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast CancerTerminatedNCT00972023Phase 1Results posted
- Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)TerminatedNCT00948857Phase 2/3Results posted
- Vaginal Prasterone Versus Estriol in Women With Pelvic Floor DisordersCompletedNCT07854873Not applicable
- Local DHEA and Estradiol on Dyspareunia in Postmenopausal WomenCompletedNCT05586711Phase 4
- GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.CompletedNCT05562518Phase 4
- Effectiveness of Adjuvant Supplements Prior to in IVFCompletedNCT05471453Not applicable
- Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal WomenCompletedNCT05316272Not applicable
- A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal AtrophyCompletedNCT04982692Phase 3
- Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular PainStatus unknownNCT04898556Phase 3
- Vaginal Prasterone In Vaginal Atrophy In Breast Cancer SurvivorsCompletedNCT04705883Phase 4
- Does DHEA IVF Outcomes in Poor Responders?SuspendedNCT04066478Phase 2/3
- Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)CompletedNCT03967964Phase 1
- Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal WomenWithdrawnNCT03854396Phase 3
- Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal AtrophyStatus unknownNCT03782480Phase 3
- Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast CancerWithdrawnNCT03740945Phase 3
- Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second StudyWithdrawnNCT03619005Phase 3
- Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With DyspareuniaCompletedNCT03568604Phase 4
- Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian RespondersCompletedNCT03438812Not applicable
- How DHEA Supplements Affect Coagulation in Women Using Birth Control PillsCompletedNCT03418363Phase 4
- Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)CompletedNCT03287232Phase 3
- Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) CyclesCompletedNCT02866253Phase 4
- Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSIStatus unknownNCT02766764Phase 4
- Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian ResponseStatus unknownNCT02736591Phase 3
- DHEA in Synovial Sarcoma PatientsTerminatedNCT02683148Phase 1
- DHEA Versus Placebo in Women With Poor Ovarian ResponseStatus unknownNCT02561793Phase 3
- Testosterone Gel in Poor Responders Undergoing IVFWithdrawnNCT02549690Not applicable
- Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian ReserveCompletedNCT02268032Phase 1
- Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?CompletedNCT02151006Phase 3
- Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian ReserveCompletedNCT02150330Phase 3
- Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVFStatus unknownNCT02099916Phase 2/3
- A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)TerminatedNCT02000375Phase 2
- Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVFCompletedNCT01915186Not applicable
- Effects of Androgen Administration on Inflammation in Normal WomenCompletedNCT01753037Not applicable
- Vaginal DHEA for Women After Breast CancerWithdrawnNCT01724242Phase 2/3
- Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian AgingCompletedNCT01572025Phase 3
- Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization PatientsCompletedNCT01535872Phase 3
- Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal WomenCompletedNCT01452373Phase 3
- The Use of DHEA in Women With Premature Ovarian FailureWithdrawnNCT01129947Early Phase 1
- The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian ReserveTerminatedNCT01129830Early Phase 1
- Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire DisorderStatus unknownNCT00916396Not applicable
- The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male SmokersCompletedNCT00900900Phase 2
- Effects of DHEA/Exercise on Bone, Muscle and BalanceCompletedNCT00664053Phase 4
- Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained InfertilityTerminatedNCT00650754Phase 2/3
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes MellitusCompletedNCT00607646Early Phase 1
- Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal InsufficiencyCompletedNCT00575341Phase 3
- DHEA Supplementation for Low Ovarian Response IVF PatientsStatus unknownNCT00549081Not applicable
- Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast CancerTerminatedNCT00516542Phase 1
- Six Months DHEA Treatment in Female Adrenal FailureCompletedNCT00471900Not applicable
- Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum MalariaSuspendedNCT00442403Phase 3
- Does DHEA Enhance the Effects of Exercise in Postmenopausal Women?CompletedNCT00434915Not applicable
- DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal AtrophyCompletedNCT00429806Phase 1
- A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)TerminatedNCT00419913Phase 2/3
- Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's SyndromeCompletedNCT00391924Phase 2
- Effect of Dehydroepiandrosterone (DHEA) on Hot Flashes in Postmenopausal WomenCompletedNCT00317148Phase 2/3
- Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor SymptomsCompletedNCT00289926Phase 3
- Effect of DHEA on Skin Aging in Postmenopausal WomenCompletedNCT00248989Phase 3
- Effects of DHEA and Exercise in the ElderlyCompletedNCT00205686Phase 3
- ANDRO 2002: Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual DysfunctionCompletedNCT00202163Phase 2
- Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) PreventionCompletedNCT00189124Phase 2/3
- Biological Effects of Dehydroepiandrosterone (DHEA) in the ElderlyCompletedNCT00111930Not applicable
- An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's DiseaseCompletedNCT00106314Phase 2
- Biologic Effects of Dehydroepiandrosterone (DHEA) in HumansCompletedNCT00099697Not applicable
- GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With GlucocorticoidsCompletedNCT00082511Phase 3
- Dehydroepiandrosterone Effects on HIV-1 ReplicationCompletedNCT00065104Phase 2
- To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With GlucocorticoidsStatus unknownNCT00053560Phase 3
- Study of GL701 in Men With Systemic Lupus ErythematosusStatus unknownNCT00037128Phase 3
- Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT00004795Phase 2/3
- Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus ErythematosusCompletedNCT00004665Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus ErythematosusCompletedNCT00004662Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal InsufficiencyCompletedNCT00004313Phase 3
- DHEA Treatment for Sjogren's SyndromeCompletedNCT00001598Phase 2
- Treatment of Mid-Life-Related Mood DisordersCompletedNCT00001487Phase 2